Lab
Adventist Health System-Sunbelt, INC
Adventist Health System-Sunbelt, INC was paid $28.27M by Medicaid between Apr 2022 and Dec 2024, across 195 billing codes. Its largest line is 99283, emergency room visit (moderate) — 38% of everything it billed.
33Billing provider infoADVENTIST HEALTH SYSTEM-SUNBELT, INC
ORLANDO, FL 32803
ORLANDO, FL 32803
33aNPI1801569728assigned 07/27/2021
33bProvider typeClinical Medical Laboratory
28Total paid$28.27M
24GClaims637,664
24DCodes billed195
24AFirst – last monthApr 2022 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Florida
Rank by total paid#7 of 225
Median peer was paid$74K
This provider vs. median384×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 74,425 | $2.20M | |
| 2023 | 375,382 | $17.71M | |
| 2024incomplete | 187,857 | $8.36M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 38% | 100,119 | 83,928 | $10.83M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 31% | 73,293 | 62,170 | $8.81M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.6% | 24,022 | 20,546 | $2.43M |
| 01999 | 3.3% | 2,391 | 2,183 | $941K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.0% | 15,607 | 13,713 | $848K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2.3% | 5,343 | 1,488 | $664K |
| D2930 | Prefabricated stainless steel crown - primary tooth | 2.1% | 1,232 | 655 | $596K |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 1.6% | 3,223 | 246 | $455K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.5% | 13,046 | 11,942 | $429K |
| G0378 | Hospital observation service, per hour | 1.5% | 2,800 | 2,348 | $427K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 2,276 | 2,094 | $255K |
| 92587 | <1% | 4,681 | 4,328 | $217K |
183 more codes
| D7140 | Extraction, erupted tooth or exposed root | <1% | 704 | $165K |
| 54161 | <1% | 143 | $164K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 9,152 | $129K |
| 59025 | Fetal non-stress test | <1% | 1,309 | $95K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 318 | $77K |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 242 | $72K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 12,033 | $71K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 5,682 | $64K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,111 | $56K |
| D2932 | <1% | 92 | $51K | |
| 97161 | <1% | 556 | $48K | |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | <1% | 1,593 | $37K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 52 | $32K |
| D1120 | Dental cleaning, child | <1% | 959 | $25K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 274 | $25K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 67 | $22K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 425 | $15K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,724 | $14K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 28,014 | $13K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 137 | $13K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | <1% | 1,493 | $12K |
| D2740 | Crown - porcelain/ceramic | <1% | 30 | $11K |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | <1% | 648 | $11K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 166 | $10K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 524 | $10K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 15 | $10K |
| 97164 | <1% | 86 | $9K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 14,309 | $8K |
| 80053 | Comprehensive metabolic panel | <1% | 65,570 | $8K |
| D0272 | Bitewings - two radiographic images | <1% | 73 | $7K |
| 97602 | <1% | 60 | $6K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 72,293 | $6K |
| 83970 | <1% | 611 | $6K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,628 | $6K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 12,177 | $6K |
| 92650 | <1% | 97 | $4K | |
| 97116 | <1% | 365 | $4K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 2,140 | $3K |
| 96367 | <1% | 70 | $3K | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 479 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 13 | $3K |
| 71045 | Radiologic examination, chest; single view | <1% | 7,897 | $3K |
| D2940 | <1% | 400 | $2K | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | <1% | 932 | $2K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 46 | $1K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 30 | $1K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 8,578 | $1K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 573 | $1K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,999 | $926.08 |
| D1330 | <1% | 633 | $862.23 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,318 | $830.97 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,731 | $822.70 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 810 | $812.34 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,171 | $756.58 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,700 | $635.47 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 116 | $597.91 |
| 96409 | <1% | 14 | $555.26 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,968 | $500.46 |
| D1310 | <1% | 618 | $490.51 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,089 | $490.07 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,025 | $460.45 |
| 87070 | <1% | 267 | $432.25 | |
| 81513 | <1% | 16 | $380.16 | |
| 81001 | <1% | 20,301 | $303.73 | |
| 80061 | Lipid panel | <1% | 2,650 | $296.99 |
| D0220 | Intraoral - periapical first radiographic image | <1% | 66 | $276.27 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,212 | $276.27 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 790 | $276.27 |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 372 | $268.24 |
| 84466 | <1% | 1,472 | $265.88 | |
| 84484 | <1% | 4,326 | $264.02 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,255 | $263.29 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 945 | $254.69 |
| 82728 | <1% | 1,471 | $240.29 | |
| 86850 | <1% | 274 | $237.45 | |
| 83735 | <1% | 3,674 | $236.43 | |
| 83880 | <1% | 544 | $235.01 | |
| 82607 | <1% | 999 | $233.57 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,989 | $217.05 |
| 86901 | <1% | 495 | $207.60 | |
| 83615 | <1% | 420 | $206.96 | |
| 84703 | <1% | 3,002 | $196.90 | |
| 86900 | <1% | 492 | $191.36 | |
| 86592 | <1% | 718 | $191.09 | |
| 86803 | <1% | 689 | $185.33 | |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | <1% | 96 | $184.18 |
| 86300 | <1% | 167 | $178.87 | |
| 85027 | <1% | 2,181 | $176.52 | |
| 81025 | <1% | 12,959 | $159.04 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 283 | $156.46 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 928 | $154.65 |
| D1206 | Topical application of fluoride varnish | <1% | 344 | $152.64 |
| 87481 | <1% | 16 | $152.24 | |
| 87340 | <1% | 630 | $142.24 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,368 | $135.23 |
| 83540 | <1% | 1,584 | $133.77 | |
| 82746 | <1% | 572 | $132.64 | |
| 83020 | <1% | 82 | $131.91 | |
| 84100 | <1% | 1,911 | $129.72 | |
| 84439 | <1% | 1,179 | $128.11 | |
| 80197 | <1% | 636 | $127.83 | |
| 82784 | <1% | 432 | $115.49 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,794 | $100.69 |
| 87186 | <1% | 471 | $98.33 | |
| 74018 | <1% | 115 | $92.09 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 297 | $92.09 |
| 87077 | <1% | 573 | $83.99 | |
| 82570 | <1% | 836 | $66.32 | |
| 85610 | <1% | 1,679 | $65.78 | |
| 83690 | <1% | 5,602 | $63.58 | |
| 86140 | <1% | 1,188 | $57.60 | |
| 84481 | <1% | 292 | $55.14 | |
| 83525 | <1% | 253 | $45.42 | |
| A0425 | Ground mileage, per statute mile | <1% | 57 | $44.93 |
| 84403 | <1% | 125 | $44.46 | |
| 82977 | <1% | 18 | $37.38 | |
| 86762 | <1% | 27 | $28.65 | |
| 81003 | <1% | 2,003 | $25.68 | |
| 84270 | <1% | 51 | $25.17 | |
| 85007 | <1% | 493 | $25.05 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 921 | $22.78 |
| 85652 | <1% | 684 | $22.60 | |
| 86706 | <1% | 84 | $19.46 | |
| 84156 | <1% | 238 | $18.60 | |
| 86038 | <1% | 88 | $16.46 | |
| 82043 | <1% | 366 | $16.20 | |
| 86376 | <1% | 43 | $15.78 | |
| 82378 | <1% | 18 | $15.75 | |
| 84550 | <1% | 71 | $15.41 | |
| 84146 | <1% | 49 | $12.85 | |
| 82950 | <1% | 85 | $8.19 | |
| 82248 | <1% | 597 | $7.08 | |
| 82947 | <1% | 1,126 | $6.26 | |
| 82550 | <1% | 329 | $5.25 | |
| 85730 | <1% | 600 | $4.73 | |
| 87210 | <1% | 268 | $3.15 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 678 | $0.97 |
| J2501 | Injection, paricalcitol, 1 mcg | 0% | 1,671 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 2,390 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 291 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 68 | $0.00 |
| 85018 | 0% | 116 | $0.00 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 308 | $0.00 |
| A0427 | Emergency ambulance ride, advanced life support | 0% | 42 | $0.00 |
| 97010 | 0% | 27 | $0.00 | |
| 84153 | 0% | 54 | $0.00 | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 0% | 33 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 181 | $0.00 |
| 85379 | 0% | 40 | $0.00 | |
| 96376 | 0% | 68 | $0.00 | |
| 83002 | 0% | 12 | $0.00 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 0% | 46 | $0.00 |
| 83001 | 0% | 64 | $0.00 | |
| 76801 | 0% | 18 | $0.00 | |
| D0230 | Intraoral - periapical each additional radiographic image | 0% | 59 | $0.00 |
| 87205 | 0% | 15 | $0.00 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 15 | $0.00 |
| 87040 | 0% | 14 | $0.00 | |
| 86364 | 0% | 26 | $0.00 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 0% | 19 | $0.00 |
| 82657 | 0% | 12 | $0.00 | |
| 99406 | 0% | 17 | $0.00 | |
| 76819 | Fetal biophysical profile; without non-stress testing | 0% | 17 | $0.00 |
| J0736 | Injection, clindamycin phosphate, 300 mg | 0% | 309 | $0.00 |
| 84702 | 0% | 290 | $0.00 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 291 | $0.00 |
| 87497 | 0% | 98 | $0.00 | |
| 86787 | 0% | 15 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 0% | 382 | $0.00 |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 0% | 36 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 2,182 | $0.00 |
| 82010 | 0% | 27 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 61 | $0.00 |
| 85014 | 0% | 16 | $0.00 | |
| 87799 | 0% | 40 | $0.00 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 87 | $0.00 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 0% | 26 | $0.00 |
| 84520 | 0% | 41 | $0.00 | |
| 82108 | 0% | 35 | $0.00 | |
| Q0511 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period | 0% | 14 | $0.00 |
| 84145 | 0% | 18 | $0.00 | |
| 80074 | 0% | 17 | $0.00 | |
| 86003 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHILLIARD, DOUGLAS (CFO)
Parent organizationADVENTIST HEALTH SYSTEM-SUNBELT, INC